CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $819K of Corcept Therapeutics Incorporated
Sold$819,400
$40.97Price
20,000Shares
−90%Stake
What CORT did after the filing
- The stock from Thu, Apr 9 open, $41.73
- +43.0%
- S&P 500, same days
- +10.1%
Measured over 30 trading days, to the May 21 close.
Traded Tue, Apr 7. Filed Wed, Apr 8, 7:34 PM ET, after the close. Returns use the Apr 9 open and the May 21 close. Not investment advice.